A randomized trial comparing anti-interleukin-2 receptor antibody and placebo for immunosuppressive therapy after OLT.
Langrehr
J M
JM
Department of Surgery, Virchow-Klinikum, Humboldt University Berlin, Germany.
Glanemann
M
M
Schneller
A
A
Neumann
U
U
Guckelberger
O
O
Lohmann
R
R
Klupp
J
J
Jonas
S
S
Knoop
M
M
Lobeck
H
H
Schlag
H
H
Keck
H
H
Settmacher
U
U
Bechstein
W O
WO
Neuhaus
P J
PJ
D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007677:Kidney Function Tests; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011239:Prednisolone / Q000627:therapeutic use; D015375:Receptors, Interleukin-2 / Q000276:immunology; D015996:Survival Rate; D013997:Time Factors
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D010919:Placebos; D015375:Receptors, Interleukin-2; D016572:Cyclosporine; D011239:Prednisolone; C079843:inolimomab; D001379:Azathioprine